Pfizer Inc. 's former senior vice president of medicinal sciences, Tony Wood , has been appointed GlaxoSmithKline PLC 's senior vice president, platform technology and science, pharma R&D – eff
The immuno-oncology company Neon Therapeutics has appointed Richard Gaynor president of research and development. Gaynor will succeed interim chief scientific officer, Robert Tepper, a partner
Over the last three decades, digital technologies have transformed lifestyles, livelihoods and businesses, creating new wealth, industrial sectors and opportunities. The impact of synthetic biology –
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc